Candel Therapeutics, Inc. (CADL) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 197.75M | 119.73M | 90.13M | 103.61M | 93.15M | 103.8M | 18.09M | 22.73M | 27.14M | 36.8M | 45.1M | 53.36M | 61.88M | 71.94M | 79.07M | 87.33M | 95.65M | 84.94M | 90.95M | 24.43M |
| Cash & Short-Term Investments | 194.83M | 119.73M | 86.96M | 100.69M | 92.17M | 102.65M | 16.56M | 21.45M | 25.71M | 35.41M | 42.98M | 51.89M | 59.26M | 70.06M | 77.18M | 86.78M | 94.32M | 82.64M | 88.39M | 24.32M |
| Cash Only | 194.83M | 119.73M | 86.96M | 100.69M | 92.17M | 102.65M | 16.56M | 21.45M | 25.71M | 35.41M | 42.98M | 51.89M | 59.26M | 70.06M | 77.18M | 86.78M | 94.32M | 82.64M | 88.39M | 24.32M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 2.92M | 0 | 3.17M | 2.92M | 983K | 0 | 1.53M | 1.28M | 0 | 1.38M | 0 | 0 | 2.62M | 1.89M | 0 | 0 | 0 | 2.3M | 0 | 110K |
| Total Non-Current Assets | 4.17M | 5.46M | 3.46M | 2.36M | 2.76M | 3.06M | 3.43M | 3.75M | 4.08M | 4.91M | 4.96M | 5.35M | 5.36M | 6.57M | 5.94M | 5.97M | 5.92M | 4.26M | 5.01M | 6.32M |
| Property, Plant & Equipment | 3.64M | 0 | 3.11M | 2.05M | 2.43M | 2.73M | 3.09M | 3.4M | 3.71M | 4.02M | 4.55M | 4.92M | 5.1M | 5.48M | 5.67M | 5.71M | 5.48M | 3.84M | 4.59M | 4.61M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 416K | 0 | 266K | 266K | 0 | 266K | 0 | 0 | 266K | 0 | 0 | 0 | 266K | 0 | 0 | 0 | 424K | 0 | 0 |
| Other Non-Current Assets | 524K | 5.05M | 351K | 45K | 58K | 329K | 75K | 347K | 368K | 116K | 405K | 425K | 266K | 0 | 266K | 266K | 437K | 0 | 423K | 1.71M |
| Total Assets | 201.92M | 125.19M | 93.6M | 105.97M | 95.91M | 106.87M | 21.52M | 26.48M | 31.22M | 41.7M | 50.06M | 58.71M | 67.24M | 78.52M | 85.01M | 93.3M | 101.56M | 89.2M | 95.96M | 30.74M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Asset Growth % | 110.54% | 17.15% | 335% | 300.11% | 207.22% | 156.26% | -57.02% | -54.89% | -53.57% | -46.89% | -41.11% | -37.08% | -33.8% | -11.98% | -11.41% | 203.48% | 189.4% | 133.02% | - | - |
| Total Current Liabilities | 7.05M | 9M | 10.93M | 14.71M | 20.07M | 37.53M | 15.27M | 14M | 13.54M | 14.18M | 10.33M | 8.16M | 5.24M | 5.62M | 5.9M | 5.88M | 5.47M | 5.36M | 4.4M | 4.49M |
| Accounts Payable | 3.04M | 1.13M | 1.12M | 1.95M | 760K | 237K | 296K | 433K | 472K | 422K | 250K | 480K | 592K | 380K | 970K | 1.58M | 1.39M | 1.59M | 925K | 759K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 453K | 445K | 4.66M | 6.7M | 9.17M | 9.89M | 10.4M | 10.35M | 9.77M | 9.41M | 6.1M | 3.65M | 1.25M | 464K | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 67K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.5M | 3.47M | 5.15M | 1.15M | 6.84M | 22.11M | -552K | 655K | 0 | 2.34M | 48K | 48K | 48K | 2.12M | 31K | 63K | 94K | 1.68M | 229K | 2.63M |
| Current Ratio | 28.05x | 13.31x | 8.25x | 7.04x | 4.64x | 2.77x | 1.18x | 1.62x | 2.00x | 2.59x | 4.37x | 6.54x | 11.82x | 12.81x | 13.41x | 14.86x | 17.48x | 15.84x | 20.68x | 5.44x |
| Quick Ratio | 28.05x | 13.31x | 8.25x | 7.04x | 4.64x | 2.77x | 1.18x | 1.62x | 2.00x | 2.59x | 4.37x | 6.54x | 11.82x | 12.81x | 13.41x | 14.86x | 17.48x | 15.84x | 20.68x | 5.44x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 56.84M | 64.28M | 2.54M | 1.04M | 1.16M | 3.01M | 21.51M | 22.46M | 11.7M | 14.77M | 16.71M | 19.77M | 22.35M | 25.19M | 26.98M | 27.35M | 32.33M | 19.71M | 28.58M | 20.36M |
| Long-Term Debt | 1.34M | 1.46M | 1.57M | 939K | 904K | 2.6M | 5.07M | 7.51M | 9.96M | 12.38M | 15.06M | 17.4M | 19.7M | 20.85M | 20.75M | 20.63M | 20.52M | 560K | 541K | 521K |
| Capital Lease Obligations | 0 | 0 | 0 | 104K | 257K | 407K | 555K | 698K | 837K | 973K | 1.11M | 1.24M | 1.36M | 1.49M | 1.61M | 1.73M | 1.84M | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 501K | 0 | 0 | 0 | 828K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 55.5M | 62.82M | 973K | 0 | 0 | 0 | 15.89M | 14.25M | 909K | 916K | 541K | 1.13M | 1.16M | 1.88M | 4.63M | 5M | 9.96M | 19.15M | 28.04M | 19.78M |
| Total Liabilities | 63.89M | 73.27M | 13.47M | 15.76M | 21.23M | 40.54M | 36.77M | 36.46M | 25.24M | 28.96M | 27.04M | 27.94M | 27.59M | 30.8M | 32.88M | 33.23M | 37.8M | 25.07M | 32.97M | 24.86M |
| Total Debt | 1.8M | 1.9M | 6.23M | 8.34M | 10.91M | 13.47M | 16.57M | 19.1M | 21.09M | 22.76M | 22.77M | 22.78M | 22.79M | 22.8M | 22.81M | 22.8M | 22.79M | 560K | 541K | 521K |
| Net Debt | -193.04M | -117.83M | -80.73M | -92.35M | -81.25M | -89.18M | 17K | -2.35M | -4.63M | -12.65M | -20.21M | -29.11M | -36.47M | -47.26M | -54.38M | -63.99M | -71.53M | -82.08M | -87.84M | -23.8M |
| Debt / Equity | 0.01x | 0.04x | 0.08x | 0.09x | 0.15x | 0.20x | - | - | 3.53x | 1.79x | 0.99x | 0.74x | 0.57x | 0.48x | 0.44x | 0.38x | 0.36x | 0.01x | 0.01x | 0.09x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -4.67x | -19.83x | -68.99x | -19.32x | 25.11x | -35.08x | -20.86x | -38.22x | -11.73x | -15.49x | -11.61x | -13.93x | -13.44x | - | -15.74x | -8.54x | -51.35x | 146.09x | -564.14x | -313.07x |
| Total Equity | 138.03M | 51.92M | 80.12M | 90.21M | 74.67M | 66.33M | -15.26M | -9.97M | 5.98M | 12.74M | 23.02M | 30.77M | 39.65M | 47.71M | 52.13M | 60.07M | 63.76M | 64.14M | 62.99M | 5.88M |
| Equity Growth % | 84.84% | -21.72% | 625.16% | 1004.63% | 1148.95% | 420.42% | -166.27% | -132.41% | -84.92% | -73.29% | -55.83% | -48.78% | -37.81% | -25.61% | -17.24% | 920.76% | 195.7% | 372.21% | - | - |
| Book Value per Share | 2.21 | 0.95 | 1.46 | 1.75 | 2.36 | 1.86 | -0.48 | -0.33 | 0.20 | 0.44 | 0.80 | 1.06 | 1.37 | 1.65 | 1.80 | 2.09 | 2.22 | 2.75 | 2.70 | 0.24 |
| Total Shareholders' Equity | 138.03M | 51.92M | 80.12M | 90.21M | 74.67M | 66.33M | -15.26M | -9.97M | 5.98M | 12.74M | 23.02M | 30.77M | 39.65M | 47.71M | 52.13M | 60.07M | 63.76M | 64.14M | 62.99M | 5.88M |
| Common Stock | 733K | 550K | 550K | 549K | 493K | 469K | 322K | 303K | 292K | 290K | 290K | 290K | 290K | 290K | 290K | 290K | 287K | 286K | 286K | 117K |
| Retained Earnings | -239.25M | -230.39M | -200.89M | -189.62M | -184.83M | -192.21M | -178.13M | -167.49M | -145.25M | -137.03M | -125.93M | -117.5M | -107.88M | -99.09M | -94.01M | -85.32M | -81.17M | -80.3M | -81.89M | -65.73M |
| Treasury Stock | 0 | -448K | 0 | -448K | -448K | -448K | -448K | -448K | -448K | -448K | -448K | -448K | -448K | -448K | -448K | -448K | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |